TrialTransplantation2018

Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.

Luciano Potena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.